WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'7401 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 9'2331 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 1'377'065  1'368'440  1'359'821  1'351'248  1'342'733  1'280'429  1'165'429  984'016 
Births 18'455  18'375  18'204  17'945  17'625  16'111  26'447  21'018 
Surviving infants 18'203  18'108  17'920  17'648  17'316  15'719  25'601  20'184 
Pop. less than 5 years 88'934  87'400  85'579  84'172  83'030  83'372  136'835  98'790 
Pop. less than 15 years 247'738  246'604  246'707  248'516  251'698  327'734  341'465  348'344 
Female 15-49 years 375'435  377'356  378'179  378'186  377'027  347'573  306'018  232'603 

Number of reported case

(Click for retrospective incidence data for China)
Diphtheria 19  421  9'767 
Japanese encephalitis 1'763  1'625  2'541  3'913  2'975 
Measles 6'183  9'943  38'159  52'461  131'441  71'093  85'705  1'122'285 
Mumps 479'518  454'385  298'932  299'329  310'826 
Pertussis 2'183  2'517  1'764  1'612  2'387  5'561  20'015  613'648 
Polio* 21  5'065  7'442 
Rubella 40'156  65'549  43'117  69'860  120'354 
Rubella (CRS)
Tetanus (neonatal) 674  1'057  1'412  1'786  3'230 
Tetanus (total) 1'786 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for China)
Vaccine year result method % card seen                                                
BCG 2007  99  HHS     99  100  100  100  97  85  99 
DTP1          99  100  100  99  99 
DTP3 2007  91  HHS     99  100  100  99  97  85  97 
HepB_BD          96  95  92  93  91 
HepB3 2007  93  HHS     99  100  100  99  95  60 
Hib3         
JapEnc          99  99  99 
MCV 2007  92  HHS     99  100  99  99  98  98 
MCV2          99  99  99  98 
PCV1         
PCV3         
Pol3 2007  92  HHS     99  100  100  99  99  90  98 
Rota1         
Rota_last         
Rubella1          99  99  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for China)
BCG 99  99  99  99  97  84  99 
DTP1 99  99  99  99  99  94  98 
DTP3 99  99  99  99  97  85  97 
HepB3 99  99  99  99  95  60 
Hib3
MCV 99  99  99  99  97  84  98 
PCV3
Pol3 99  99  99  99  99  86  98 
Rota_last

Number of districts in the country 2'956  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTaP 3, 4, 5, 18 months; Yes
HepA 18 months; Yes
HepB birth; 1, 6 months; Yes
JapEnc 8 months; 2 years; Yes
MMR 18 months; Yes
MR 8 months; Yes
MenA 6-18 months (x2); Yes polysaccharide
MenAC 3, 6 years; Yes
OPV 2, 3, 4 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015        NA 
Nº of districts with microplans that include activities to raise immunization coverage number         2'859  3'132  3'132 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 2'956  3'092  3'092  3'118  3'105  3'132  3'132 
Nº districts with DTP3 coverage >=80% number 2'955  3'048  3'038  3'093  3'094  3'023  3'114 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  99  98  99  100  97  99 
Nº districts with measles (MCV1) coverage >=95% number 2'913  3'002  2'983  2'812       
% of districts with MCV1 coverage >=95% From 0 to 100% 99  97  96  90       

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100    100       

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.